Renata Medical

Executive Summary

Renata Medical is a US-based medical device company dedicated to addressing critical unmet needs in pediatric congenital heart disease (CHD). Its flagship product, the Minima Stent System, is the only FDA-approved stent specifically designed for treating vascular stenosis in neonates and infants. With a focus on accommodating a child's growth, the Minima Stent represents a significant advancement in pediatric interventional cardiology. The company is privately held and operates from Menlo Park, California. Renata's approved product and focused pipeline position it as a leader in the niche pediatric cardiovascular market, with potential for expanding indications and geographic reach.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch acceleration and US market penetration of Minima Stent85% success
• Q2 2027FDA clearance for expanded indication (e.g., older pediatric patients or additional vascular lesions)60% success
• Q1 2027CE marking and European market entry for Minima Stent70% success